Showing results 1 to 20 of 51
next >
| Issue Date | Title | Author(s) |
| 2018-06-01 | Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord | Winters, BL; Rawling, T; Vandenberg, RJ; Christie, MJ; Bhola, RF; Imlach, WL |
| 2016-11-06 | Alkaloid-like Molecules for Drug Discovery | Williams, SG; Rawling, T; Ung, AT |
| 2013-01-01 | Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cells | Cui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M |
| 2015-06-01 | Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs | Murray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T |
| 2017-01-01 | Antiproliferative activities of alkaloid-like compounds | Xu, X; Rawling, T; Roseblade, A; Bishop, R; Ung, AT |
| 2020 | Antiproliferative activities of tricyclic amides derived from β-caryophyllene via the Ritter reaction against MDA-MB-231 breast cancer cells | Xu, X; Roseblade, A; Rawling, T; Ung, AT |
| - | Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporter | Rawling, T; MacDermott-Opeskin, H; Roseblade, A; Pazderka, C; Clarke, C; Bourget, K; Wu, X; Lewis, W; Noble, B; Gale, PA; O'Mara, ML; Cranfield, C; Murray, M |
| 2019-03-01 | Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells | Al-Zubaidi, Y; Pazderka, C; Koolaji, N; Rahman, MK; Choucair, H; Umashankar, B; Bourget, K; Chen, Y; Rawling, T; Murray, M |
| 2018-05-23 | Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell Death | Koolaji, N; Rawling, T; Bourget, K; Murray, M |
| 2013-12-17 | Cell-derived microparticles: New targets in the therapeutic management of disease | Roseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M |
| 2008-07-08 | Convenient synthesis and purification of [Bu<inf>4</inf>N] <inf>2</inf>[Ru(4-carboxy-4-carboxylate-2,2′-bipyridine) <inf>2</inf>(NCS)<inf>2</inf>]: A landmark DSC Dye | Rawling, T; Buchholz, F; McDonagh, AM |
| 2019-03-14 | Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 to Produce Analgesia in a Rat Model of Chronic Pain | Mostyn, SN; Rawling, T; Mohammadi, S; Shimmon, S; Frangos, ZJ; Sarker, S; Yousuf, A; Vetter, I; Ryan, RM; Christie, MJ; Vandenberg, RJ |
| 2018-03-01 | Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver | Murray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T |
| 2021-02-05 | Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite. | Nair, PC; Gillani, TB; Rawling, T; Murray, M |
| 2020-08-16 | Expansion of the structure-activity relationship of branched chain fatty acids: effect of unsaturation and branching group size on anticancer activity. | Roy, R; Roseblade, A; Rawling, T |
| 2010-02-01 | Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: Monounsaturated omega-3 fatty acids | Rawling, T; Duke, CC; Cui, PH; Murray, M |
| 2011-05-01 | Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MS | Austin, C; Fryer, F; Lear, J; Bishop, D; Hare, D; Rawling, T; Kirkup, L; McDonagh, A; Doble, P |
| 2023-07-31 | Fatty Acid-Activated Proton Transport by Bisaryl Anion Transporters Depolarises Mitochondria and Reduces the Viability of MDA-MB-231 Breast Cancer Cells. | York, E; McNaughton, DA; Duman, M-N; Gale, PA; Rawling, T |
| 2019-10-01 | Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics | Mostyn, SN; Wilson, KA; Schumann-Gillett, A; Frangos, ZJ; Shimmon, S; Rawling, T; Ryan, RM; O’mara, ML; Vandenberg, RJ |
| 2020-10 | Identification of N-acyl amino acids that are positive allosteric modulators of glycine receptors. | Gallagher, CI; Sheipouri, D; Shimmon, S; Rawling, T; Vandenberg, RJ |
